Immunisation with life-saving vaccines is one of the greatest achievements in public health, but a growing wave of misinformation/disinformation in the wake of the COVID-19 pandemic threatens to undermine the many successes of vaccination.

Immunosenescence, age-related immune dysregulation, reduces immunity upon vaccinations and infections.

A new joint action focusing on tackling chronic respiratory diseases was recently launched. Backed by the EU4Health programme, the 3-year initiative aims to improve lung health across Europe through innovative digital health technologies.

Launched in Brussels on 30 January to drive political momentum for broader vaccine uptake across all stages of life. The group is co-chaired by Croatian MEP Tomislav Sokol and Lithuanian MEP Vytenis Andriukaitis, a former European Commissioner for Health.

Human parainfluenza virus type 3 (HPIV-3) can cause severe respiratory tract infections. There are no convenient small-animal infection models.

The long-term physiological consequences of respiratory viral infections, particularly in the aftermath of the COVID-19 pandemic—termed post-acute sequelae of SARS-CoV-2 (PASC)—are rapidly evolving into a major public health concern.

Vaccination against respiratory viruses can reduce the risk of complications associated with CVDs.

ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.